PHARMA: Is Crestor the next Vioxx?

Five drugs are in risk of being the next Vioxx, the Senate panel looking at Vioxx was told this morning. The remark was made by the US FDA reviewer who is not allowed on the Bextra review panel as he’s already made his call about that one (thumbs down). Crestor, which has been multo discussed on TCHB over the last 18 months is on his list (as is Bextra), and Astra Zeneca’s stock fell nearly 10% as a consequence.

Categories: Uncategorized

Tagged as: ,